STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

PRSO insider grant: 25,000 options vest monthly over 3 years

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Peraso Inc. insider grant: Ronald Glibbery, who is listed as both Chief Executive Officer and a director of Peraso Inc. (PRSO), was granted a stock option on 08/07/2025 to buy 25,000 shares of common stock at an exercise price of $0.8399 per share. The option vests in 36 equal monthly installments (1/36th on each monthly anniversary beginning August 7, 2025) and the reported expiration date is August 7, 2035. The filing reports the options as directly beneficially owned by Mr. Glibbery and shows 25,000 derivative securities of this class following the transaction. No other non-derivative transactions are reported in this Form 4.

Positive

  • CEO received 25,000 stock options at an exercise price of $0.8399, aligning management incentives with shareholders
  • Vesting schedule is clear: 1/36th vests monthly beginning 08/07/2025, encouraging retention over three years

Negative

  • None.

Insights

TL;DR: Routine executive equity grant aligning CEO compensation with long-term share performance; appears non-disruptive.

The Form 4 discloses a standard option award to the CEO and director that vests monthly over three years and expires in 2035. From a governance perspective, staggered monthly vesting encourages retention and ongoing alignment with shareholder value without an immediate dilutive impact beyond the disclosed 25,000-option grant. The report indicates direct ownership of the derivative security class and does not disclose other transactions or offsets that would materially change control or capital structure.

TL;DR: Compensation grant is modest in size and structured for retention; impact on financials and dilution is likely limited.

This option award carries an exercise price of $0.8399 and vests 1/36th monthly beginning on the grant date, implying full vesting after three years and an expiration date a decade after grant. The disclosure shows 25,000 options outstanding to the reporting person in this derivative class post-transaction. There is no cash payment for the grant indicated in the Form 4 and no concurrent disposals or exercises reported that would alter immediate share count.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Glibbery Ronald

(Last) (First) (Middle)
2033 GATEWAY PLACE
SUITE 500

(Street)
SAN JOSE CA 95110

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Peraso Inc. [ PRSO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $0.8399 08/07/2025 A 25,000 (1) 08/07/2035 Common Stock 25,000 $0.00 25,000(2) D
Explanation of Responses:
1. The option will vest as to 1/36th of the shares subject to the option on each monthly anniversary following August 7, 2025.
2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
/s/ James Sullivan by power of attorney 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Peraso (PRSO) disclose in this Form 4?

The Form 4 discloses that CEO and director Ronald Glibbery was granted 25,000 stock options on 08/07/2025 with an exercise price of $0.8399.

How do the options vest for the PRSO grant?

The option vests as to 1/36th of the shares on each monthly anniversary following August 7, 2025, completing vesting after 36 months.

When do the granted options expire?

The Form 4 indicates an expiration date of 08/07/2035 for the reported option award.

Does the filing report ownership after the transaction?

Yes. Column 9 reports 25,000 derivative securities of the reported class beneficially owned following the transaction.

Was the option ownership direct or indirect?

The filing identifies the ownership form as Direct (D).
Peraso

NASDAQ:PRSO

PRSO Rankings

PRSO Latest News

PRSO Latest SEC Filings

PRSO Stock Data

8.41M
9.14M
2.08%
10.73%
0.18%
Semiconductors
Semiconductors & Related Devices
Link
United States
SAN JOSE